{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:11:55Z","timestamp":1790802715490,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Science and Technology Major Project of China","award":["2014ZX10003001-001"],"award-info":[{"award-number":["2014ZX10003001-001"]}]},{"name":"National Science and Technology Major Project of China","award":["2017ZX10201302-002"],"award-info":[{"award-number":["2017ZX10201302-002"]}]},{"name":"Changjiang Scholars and Innovative Research Team in University of China","award":["IRT13007"],"award-info":[{"award-number":["IRT13007"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2016-I2M-1-013"],"award-info":[{"award-number":["2016-I2M-1-013"]}]},{"name":"Jin Qi team of Sanming Project of Medicine in Shenzhen","award":["SZSM 201412001"],"award-info":[{"award-number":["SZSM 201412001"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["GCZX2015043015340574"],"award-info":[{"award-number":["GCZX2015043015340574"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jinf.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T02:07:26Z","timestamp":1525658846000},"page":"276-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reversion of QuantiFERON-TB Gold In-Tube test in individuals with and without prophylactic treatment for latent tuberculosis infection: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"77","author":[{"given":"Haoran","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henan","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2018.04.009_bib0001","unstructured":"Guidelines on the Management of Latent Tuberculosis Infection. Geneva: World Health Organization, 2015 WHO Guidelines Approved by the Guidelines Review Committee."},{"key":"10.1016\/j.jinf.2018.04.009_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0003","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMra1200894","article-title":"Tuberculosis","volume":"368","author":"Zumla","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0004","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/cir951","article-title":"Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis","volume":"54","author":"Andrews","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0005","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.286.14.1740","article-title":"Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection","volume":"286","author":"Mazurek","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2018.04.009_bib0006","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2018.04.009_bib0007","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nmni.2016.03.010","article-title":"Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays","volume":"12","author":"Bedini","year":"2016","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.jinf.2018.04.009_bib0008","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.dsi.2014.12.005","article-title":"Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy","volume":"3","author":"Cheng","year":"2015","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.jinf.2018.04.009_bib0009","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12879-015-1117-3","article-title":"Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1378\/chest.13-1232","article-title":"Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB Gold In-Tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study","volume":"145","author":"Johnson","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2018.04.009_bib0011","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jinf.2012.10.017","article-title":"Serial QuantiFERON TB-Gold In-Tube testing during LTBI therapy in candidates for TNFi treatment","volume":"66","author":"Bartalesi","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2018.04.009_bib0012","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5588\/ijtld.12.0927","article-title":"Changes in QuantiFERON(R)-TB Gold In-Tube results during treatment for tuberculous infection","volume":"17","author":"Bastos","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13555-013-0020-3","article-title":"Dynamic QuantiFERON response in psoriasis patients taking long-term biologic therapy","volume":"3","author":"Drago","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jinf.2018.04.009_bib0014","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/bjd.12544","article-title":"Interferon-gamma release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis","volume":"169","author":"Sauzullo","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jinf.2018.04.009_bib0015","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s15010-012-0265-2","article-title":"Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort","volume":"40","author":"Lee","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2018.04.009_bib0016","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/apt.12037","article-title":"Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-alpha inhibitors","volume":"36","author":"Papay","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2018.04.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/757152","article-title":"Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting","volume":"2012","author":"Takenami","year":"2012","journal-title":"Pulm Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0018","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2334-10-57","article-title":"Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country","volume":"10","author":"Dyrhol-Riise","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0019","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.rmed.2009.10.006","article-title":"Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak","volume":"104","author":"Lee","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0020","first-page":"603","article-title":"Effects of prophylaxis on QuantiFERON TB-2\u00a0G responses among children","volume":"83","author":"Higuchi","year":"2008","journal-title":"Kekkaku"},{"key":"10.1016\/j.jinf.2018.04.009_bib0021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-6673-1-7","article-title":"Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report","volume":"1","author":"Pai","year":"2006","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.jinf.2018.04.009_bib0022","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12879-014-0667-0","article-title":"HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study","volume":"14","author":"Pullar","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000001946","article-title":"High incidence of tuberculosis infection in HIV-exposed children exiting an isoniazid preventive therapy trial","author":"Cranmer","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2018.04.009_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184178","article-title":"Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab","volume":"12","author":"Hsiao","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.04.009_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ppul.21555","article-title":"Serial interferon-gamma release assay in children with latent tuberculosis infection and children with tuberculosis","volume":"47","author":"Nenadic","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jinf.2018.04.009_bib0026","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7883\/yoken.JJID.2016.480","article-title":"QuantiFERON-TB Gold In-Tube test for tuberculosis prevention in hiv-infected patients","volume":"70","author":"Khawcharoenporn","year":"2017","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12995-016-0148-z","article-title":"QFT-plus: a plus in variability? \u2013 evaluation of new generation IGRA in serial testing of students with a migration background in Germany","volume":"12","author":"Knierer","year":"2017","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.jinf.2018.04.009_bib0028","doi-asserted-by":"crossref","first-page":"e3813","DOI":"10.1097\/MD.0000000000003813","article-title":"Risk of tuberculosis among patients on dialysis: the predictive value of serial interferon-gamma release assay","volume":"95","author":"Shu","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jinf.2018.04.009_bib0029","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/infdis\/jit418","article-title":"Reversion and conversion of interferon-gamma release assay results in HIV-1-infected individuals","volume":"209","author":"Aichelburg","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0031","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1513\/AnnalsATS.201310-378OC","article-title":"IFN-gamma release assay conversions and reversions. Challenges with serial testing in U.S. health care workers","volume":"11","author":"Joshi","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jinf.2018.04.009_bib0032","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1590\/0074-0276140085","article-title":"Serial QuantiFERON-TB Gold In-Tube assay and tuberculin skin test to diagnose latent tuberculosis in household Mexican contacts: conversion and reversion rates and associated factors using conventional and borderline zone definitions","volume":"109","author":"Monarrez-Espino","year":"2014","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.jinf.2018.04.009_bib0033","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2169\/internalmedicine.53.1288","article-title":"Serial QuantiFERON TB-2\u00a0G testing over a four-year period in healthcare workers at a city hospital","volume":"53","author":"Uto","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0034","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1183\/09031936.00011914","article-title":"Serial testing using interferon-gamma release assays in nursing students in India","volume":"44","author":"Zwerling","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2018.04.009_bib0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1164\/rccm.201305-0831OC","article-title":"Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers","volume":"188","author":"Slater","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0036","doi-asserted-by":"crossref","first-page":"e58202","DOI":"10.1371\/journal.pone.0058202","article-title":"Prevalence and incidence of latent tuberculosis infection in georgian healthcare workers","volume":"8","author":"Whitaker","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.04.009_bib0037","doi-asserted-by":"crossref","first-page":"e54748","DOI":"10.1371\/journal.pone.0054748","article-title":"Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?","volume":"8","author":"Zwerling","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.04.009_bib0038","first-page":"271","article-title":"Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents","volume":"31","author":"Kim","year":"2011","journal-title":"Korean J Lab Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0039","doi-asserted-by":"crossref","first-page":"e26787","DOI":"10.1371\/journal.pone.0026787","article-title":"Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study","volume":"6","author":"Shah","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.04.009_bib0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00420-010-0571-x","article-title":"Serial testing with the interferon-gamma release assay in Portuguese healthcare workers","volume":"84","author":"Torres","year":"2011","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/j.jinf.2018.04.009_bib0041","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jinf.2010.04.010","article-title":"Serial testing of interferon-gamma-release assays for the diagnosis of latent tuberculosis in hemodialysis patients","volume":"61","author":"Chung","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2018.04.009_bib0042","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2334-10-220","article-title":"Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers","volume":"10","author":"Ringshausen","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0043","article-title":"Serial testing with an interferon-gamma release assay in German healthcare workers","volume":"5","author":"Schablon","year":"2010","journal-title":"GMS Krankenhhyg Interdiszip"},{"key":"10.1016\/j.jinf.2018.04.009_bib0044","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","article-title":"The dynamics of QuantiFERON-TB Gold In-Tube conversion and reversion in a cohort of South African adolescents","volume":"191","author":"Andrews","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0045","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1183\/09031936.00138414","article-title":"Incidence of occupational latent tuberculosis infection in South African healthcare workers","volume":"45","author":"Adams","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2018.04.009_bib0046","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s12879-014-0654-5","article-title":"QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study","volume":"14","author":"Belay","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0047","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jinf.2013.07.029","article-title":"Dynamic changes in positive interferon-gamma release assay in a dialysis population: an observational cohort study","volume":"67","author":"Shu","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2018.04.009_bib0048","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1745-6673-8-12","article-title":"The effect of introducing IGRA to screen French healthcare workers for tuberculosis and potential conclusions for the work organisation","volume":"8","author":"Moucaut","year":"2013","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.jinf.2018.04.009_bib0049","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar3882","article-title":"Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists","volume":"14","author":"Hatemi","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jinf.2018.04.009_bib0050","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1378\/chest.11-3299","article-title":"Monthly follow-ups of interferon-gamma release assays among health-care workers in contact with patients with TB","volume":"142","author":"Park","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2018.04.009_bib0051","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/291294","article-title":"Delineating a retesting zone using receiver operating characteristic analysis on serial QuantiFERON tuberculosis test results in US healthcare workers","volume":"2012","author":"Thanassi","year":"2012","journal-title":"Pulm Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0052","first-page":"84","article-title":"Use of interferon-gamma release assays in a health care worker screening program: experience from a tertiary care centre in the United States","volume":"19","author":"Joshi","year":"2012","journal-title":"Can Respir J"},{"key":"10.1016\/j.jinf.2018.04.009_bib0053","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2215\/CJN.01010208","article-title":"Interferon-gamma release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients","volume":"3","author":"Winthrop","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jinf.2018.04.009_bib0054","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/CVI.00398-07","article-title":"Reproducibility of QuantiFERON-TB Gold In-Tube assay","volume":"15","author":"Perry","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2018.04.009_bib0055","first-page":"84","article-title":"T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India","volume":"13","author":"Pai","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0056","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1086\/657336","article-title":"Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers","volume":"31","author":"Gandra","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2018.04.009_bib0057","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tube.2013.07.006","article-title":"Weakly positive tests and chronologic variation of the QuantiFERON assay: a retrospective appraisal of usefulness","volume":"93","author":"Felber","year":"2013","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0058","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1745-6673-9-24","article-title":"Tuberculosis screening at the Sainte-Anne Hospital in Paris \u2013 results of first and second IGRA","volume":"9","author":"Nienhaus","year":"2014","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.jinf.2018.04.009_bib0059","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/381754","article-title":"Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy","volume":"38","author":"Carrara","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1164\/rccm.200608-1109OC","article-title":"Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens","volume":"175","author":"Chee","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0061","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clinthera.2012.03.006","article-title":"Utility of interferon-gamma release assay results to monitor anti-tubercular treatment in adults and children","volume":"34","author":"Chiappini","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.jinf.2018.04.009_bib0062","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1471-2334-10-300","article-title":"Serial interferon-gamma release assays during treatment of active tuberculosis in young adults","volume":"10","author":"Lee","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2018.04.009_bib0063","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1164\/rccm.200511-1783OC","article-title":"Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis","volume":"174","author":"Ewer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2018.04.009_bib0064","doi-asserted-by":"crossref","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.04.009_bib0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.immunol.18.1.309","article-title":"Glucocorticoids in T cell development and function","volume":"18","author":"Ashwell","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"Suppl 3","key":"10.1016\/j.jinf.2018.04.009_bib0066","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1177\/089686080802803s34","article-title":"Characteristics and causes of immune dysfunction related to uremia and dialysis","volume":"28","author":"Hauser","year":"2008","journal-title":"Perit Dial Int"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318301129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:25:49Z","timestamp":1759008349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318301129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0163445318301129"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.04.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversion of QuantiFERON-TB Gold In-Tube test in individuals with and without prophylactic treatment for latent tuberculosis infection: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}